Gene · 11082
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogenic HPV-induced high expression of ESM1 predicts poor prognosis and regulates aerobic glycolysis in cervical cancer. | iScience | 2024 | 38947495 | PubTator, text mining | PubMed |
| Vascular endothelial growth factor and endocan expression in adrenal cortical tumors and their relationship with histopathological prognostic parameters. | Endocr J | 2024 | 38945931 | PubTator, text mining | PubMed |
| Erratum. | Medeni Med J | 2024 | 38940551 | PubTator, text mining | PubMed |
| Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis. | Medicina (Kaunas) | 2024 | 38929601 | PubTator, text mining | PubMed |
| ESM1 May Be Used as a New Indicator for the Diagnosis and Prognosis of Early and Advanced Stage Digestive Tract Cancers. | Int J Gen Med | 2024 | 38912330 | PubTator, text mining | PubMed |
| Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. | Int Immunopharmacol | 2024 | 38897128 | PubTator, text mining | PubMed |
| Ferroptosis-related lncRNAs: Distinguishing heterogeneity of the tumour microenvironment and predicting immunotherapy response in bladder cancer. | Heliyon | 2024 | 38867969 | PubTator, text mining | PubMed |
| Multiomics analysis of platelet-rich plasma promoting biological performance of mesenchymal stem cells. | BMC Genomics | 2024 | 38840037 | PubTator, text mining | PubMed |
| SOFB is a comprehensive ensemble deep learning approach for elucidating and characterizing protein-nucleic-acid-binding residues. | Commun Biol | 2024 | 38830995 | PubTator, text mining | PubMed |
Effect of nano-curcumin supplementation on angina status, and traditional and novel cardiovascular risk factors in overweight or obese patients with coronary slow flow phenomenon: a randomized double-blind placebo-controlled clinical trial. | BMC Nutr | 2024 | 38741194 | PubTator, text mining | PubMed |
| ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. | Mol Cancer | 2024 | 38720298 | PubTator, text mining | PubMed |
| Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma. | BMC Cancer | 2024 | 38714987 | PubTator, text mining | PubMed |
| Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy. | BMC Nephrol | 2024 | 38649936 | PubTator, text mining | PubMed |
| Endocan: A biomarker for endothelial dysfunction and inflammation, linking maternal obesity and pediatric obesity in a cohort of preterm neonates. | Eur J Obstet Gynecol Reprod Biol | 2024 | 38626514 | PubTator, text mining | PubMed |
| Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells. | PLoS One | 2024 | 38626010 | PubTator, text mining | PubMed |
| Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes. | Diabetes Care | 2024 | 38623619 | PubTator, text mining | PubMed |
| Esm-1 mediates transcriptional polarization associated with diabetic kidney disease. | Am J Physiol Renal Physiol | 2024 | 38601985 | PubTator, text mining | PubMed |
| Parenchymal cues define Vegfa-driven venous angiogenesis by activating a sprouting competent venous endothelial subtype. | Nat Commun | 2024 | 38600061 | PubTator, text mining | PubMed |
| Endothelial and inflammatory pathophysiology in dengue shock: New insights from a prospective cohort study in Vietnam. | PLoS Negl Trop Dis | 2024 | 38536887 | PubTator, text mining | PubMed |
| Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis. | J Transl Med | 2024 | 38532419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11082/papers?page=12